Exploring a better tomorrow
We explore. Driven by our passion for science. Boosted by our unique infrastructure. We sound out the frontiers. We expand our knowledge in various nuclear areas. However many horizons we may explore, we always pursue the same objective: developing innovative applications for society. Why do we strive for this objective? Because we are convinced that, with one of the smallest elements on earth, the atom, we can make the biggest difference for society. Both now and in the future.
IRE (Institut National des Radioéléments) and SCK CEN are joining forces to benefit medicine. Both organisations specialised in the research, development and production of medical radioisotopes, signed a public-public partnership whose initial aim is to produce lutetium-177 (Lu-177). This medical radioisotope gives a ray of hope to treat prostate cancer, which causes around 90,000 deaths per year in Europe.
- 12 November '19
- 06 August '19
- 26 June '19
- 18 March '19
From cancer research to the impact of radioactivity on the body: SCK CEN’s research knows no boundaries.
SCK CEN is working on many applications to protect people and the environment, now and in a distant future, against ionising radiation.
Any research conducted by SCK CEN has a social added value, but society is also the very subject of one specific research field.
Thanks to its knowledge in material aging, SCK CEN accurately predicts how materials (will) behave in a nuclear reactor.
SCK CEN boosts innovation in nuclear technology in various ways.
Safety is our priority, radiation protection our keyword. SCK CEN measures, monitors and analyses.
SCK CEN Academy: a matter of acquiring and sharing knowledge
Events & fairs
Continuous professional development for radiation protection experts | Nuclear and cyber security
Health effects induced by radiation and space conditions
Training course on radioactive waste management
Day of the PhDs | April 23, 2020